Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
11/2007
11/07/2007CN101068791A Method for preparing salt with tetrafluoroborate anion and reducing the content of hologenate
11/07/2007CN101068786A 3-substituted pyridine derivatives as h3 antagonists
11/07/2007CN101068785A Hydroxybenzoate salts of metanicotine compounds
11/07/2007CN101068784A Hydroxybenzoate salts of metanicotine compounds
11/07/2007CN101068783A Processes and intermediates for preparing cysteine protease inhibitors
11/07/2007CN101068776A Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
11/07/2007CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007CN101066947A Br phi nsted acid ionic liquid based on 2,4-dicarboxyl pyridine cation and its synthesis process
11/07/2007CN101066946A Process of separating methyl pyridine mixture
11/07/2007CN100347159C Cationic dimeric dyes
11/07/2007CN100346789C Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury
11/07/2007CN100346768C Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives
11/06/2007USRE39916 Compounds that modulate PPAR activity and methods for their preparation
11/06/2007US7291739 Chiral catalysts for asymmetric acylation and related transformations
11/06/2007US7291738 A (2-methyl-3-pyridinyl)oxy)-3-pyridinyl)urea derivatives for treatment of a disease or disorder of the central nervous system, medical diagnosis
11/06/2007US7291729 Reacting 2,3,4-trifluoronitrobenzene with an alkali metal aryloxide, contacting the 3,4-difluoro-2-aryloxynitrobenzene produced with an alkali metal salt of a malonate diester to replace the 4-fluoro group with the malonate; optional further hydrolysis, reduction of the NO2 group, and decarboxylation
11/06/2007US7291631 aminoalkylpyridines, e.g., N-(1H-benzimidazol-2-ylmethyl)-N-(3-methylpyridin-2-ylmethyl)-butane-1,4-diamine; treating HIV infection and inflammatory conditions such as rheumatoid arthritis; elevating progenitor and stem cell counts, as well as white blood cell counts
11/06/2007US7291617 Arylamidine derivative or salt thereof
11/06/2007US7291580 6-(1,1-difluoroalkyl)-4-aminopicolinates and their use as herbicides
11/06/2007CA2353527C Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases
11/06/2007CA2232463C Nitration of pyridine-2,6-diamines
11/06/2007CA2223112C 1,2-bis-adducts of stable nitroxides with substituted ethylenes and stabilized compositions
11/06/2007CA2180533C Process for producing aromatic or heteroaromatic sulfur compounds
11/01/2007WO2007123939A2 Novel arylamino n-heteraryls as mek inhibitors
11/01/2007WO2007123936A1 Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors
11/01/2007WO2007123910A2 Copper-mediated functionalization of aryl c-h bonds, and compounds related thereto
11/01/2007WO2007123718A1 1-HETEROCYCLYLAMINO-2-HYDROXY-3-AMINO-ω-ARYLALKANES
11/01/2007WO2007123256A1 Compound and organic light emitting device
11/01/2007WO2007123254A1 Dibenzoanthracene compound and organic light emitting device having the same
11/01/2007WO2007122340A1 Cationic dichromophoric compound containing two units of hydrazone type and comprising a cationic linker arm, dye composition comprising at least one such compound, method for the use thereof and uses
11/01/2007WO2007122197A1 2, 3, 4, 6-substituted pyridines and their use as hair dyeing compositions
11/01/2007WO2007122104A1 Dicarboxamide derivatives
11/01/2007WO2007121662A1 Diphenyl urea derivatives as kinase inhibitors, compositions and uses thereof
11/01/2007WO2007087135A3 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
11/01/2007WO2007080121A3 Process for preparing imino compounds
11/01/2007WO2007072092A3 New phenanthridine derivatives as bradykinin antagonists
11/01/2007WO2007030589A3 Pharmaceutical dosage forms and compositions comprising lecoztan
11/01/2007WO2002090332A3 Novel aeylheteroalkylaminε derivatives
11/01/2007US20070255062 Benzoyl Amino Pyridyl Carboxylic Acid Derivatives Useful as Glucokinase (Glk) Activators
11/01/2007US20070255061 5-Fluoro-, Chloro-and Cyano-Pyridin-2-Yl-Tetrazoles as Ligands of the Metabotropic Glutamate Receptor-5
11/01/2007US20070254926 Pyridylphenyl compounds for inflammation and immune-related uses
11/01/2007US20070254919 Aroyl-O-Piperidine Derivatives for the Treatment of Diabetes-Related Problems
11/01/2007US20070254890 4(Phenyl-Piperazinyl-Methyl) Benzamide Derivatives and Their Use for the Treatment of Pain or Gastrointestinal Disorders
11/01/2007US20070254886 N-[5-bromo-3-({3-[2-(dimethylamino)ethoxy]-4-methoxybenzyl}oxy)pyridin-2-yl]-4-methylbenzenesulfonamide, used for prevention and/or treatment of infections, inflammatory and/or allergic diseases
11/01/2007US20070254868 such as 3-(1-(2,3-difluorophenyl)-1H-tetrazol-5-yl)-5-(4-(4-methylpiperazin-1-yl) phenyl)pyridin-2-amine, used as anticarcinogenic agents or for the treatment of atherosclerosis and lung fibrosis
11/01/2007CA2650009A1 Il-8 receptor antagonists
11/01/2007CA2649458A1 Dicarboxamide derivatives
11/01/2007CA2644425A1 Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors
10/2007
10/31/2007EP1849773A1 Pyridyl non-aromatic nitrogenated heterocyclic-1-carboxylate ester derivative
10/31/2007EP1849500A1 2, 3, 4, 6-Substituted pyridines and their use as hair dyeing compositions
10/31/2007EP1849469A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
10/31/2007EP1848695A1 Compounds which potentiate glutamate receptor and uses thereof in medicine
10/31/2007EP1848430A2 Novel benzylamine derivatives as cetp inhibitors
10/31/2007EP1603923B9 Metal complexes
10/31/2007EP1572612B1 Dihalo-allyloxy-phenol derivatives having pesticidal activity
10/31/2007EP1512402B1 Inhibitors against complex ii of electron transport system
10/31/2007EP1390342B1 Substituted aromatic amide derivatives, intermediates thereof, agrohorticultural insecticide containing thereof and method for the use thereof
10/31/2007EP1360168A4 Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof
10/31/2007EP1246795B1 Antibacterial agents
10/31/2007EP1202978B1 Isoxazolyl- and isoxazolinyl-substituted benzoylcyclohexanediones, production method and use thereof as herbicides and plant growth regulators
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007EP1102749B1 Method for producing 2-halogen nicotinic acid derivatives and 2-chloronicotinic acid-n-butyl esters as intermediate products
10/31/2007CN101065368A Substituted oxyguanidines
10/31/2007CN101065360A Thermodynamically stable form of BAY 43-9006 tosylate
10/31/2007CN101065359A Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery
10/31/2007CN101065358A 3-arylamino pyridine derivatives
10/31/2007CN101065352A Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives
10/31/2007CN101062920A Processes for the preparation of pesticidal compounds and novel intermediates thereof
10/31/2007CN101062915A Preparation method of 2,3-dichlorin-5-trifluoro picoline
10/31/2007CN101062914A Preparation method of 2-chlorin-3-trifluoro picoline
10/31/2007CN101062907A Agmatine derivative and medicament usage thereof
10/31/2007CN100345827C Bicyclic aromatic compound
10/31/2007CN100345823C Compounds, compositions and methods
10/30/2007US7288658 Process for preparation of pyridine derivatives
10/30/2007US7288571 Thyroid receptor ligands and method II
10/30/2007US7288567 Inhibitors of histone deacetylase
10/30/2007US7288554 For agriculture crops
10/30/2007US7288544 Calcium channel antagonistic activity; especially useful as analgesics
10/30/2007US7288540 Phenylalkynes
10/25/2007WO2007120729A2 Pyridyl amide t-type calcium channel antagonists
10/25/2007WO2007120647A2 Compositions useful as inhibitors of voltage-gated sodium channels
10/25/2007WO2007120574A2 Diaryl substituted alkanes
10/25/2007WO2007118859A1 Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
10/25/2007WO2007098352A3 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors
10/25/2007WO2006103342A9 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
10/25/2007WO2003011210A3 Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
10/25/2007US20070249838 Deprotonation of pyridine, 2-fluoropyridine, or methoxypyridine with (trimethylsilylmethyl)lithium or neopentyllithium; industrial scale; direct deprotonation and minimized nucleophilic attack on an azaaromatic compound results in improved yields and simplified purification schemes for the deprotonation
10/25/2007US20070249837 reaction of a alpha - beta -unsaturated carbonyl compound with a Wittig reagent or Horner-Wadsworth-Emmons reagent in the presence of a base; regioselective; sulfonamide type herbicides; 5,5-Diethoxy-2-thiomethyl-3-trifluoromethyl-pent-2-ene-nitrile
10/25/2007US20070249832 For agriculture crops
10/25/2007US20070249816 Methods for carbon istope labeling synthesis by rhodium-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide
10/25/2007US20070249719 Compounds for the treatment of metabolic disorders
10/25/2007US20070249696 Compounds for the treatment of metabolic disorders
10/25/2007US20070249690 N-[2-(4-Pyridinyl)Ethyl]Benzamide Derivatives as Fungicides
10/25/2007US20070249688 3-{4-[1-(4'-tert-butyl-2,6-dimethyl-biphenyl-4-yloxy)-4,4,4-trifluoro-butyl]-benzoylamino}-propionic acid; treat diabetic and other glucagon related metabolic disorders
10/25/2007US20070249686 Modulators of Crth-2 Receptor Activity for the Treatment of Prostaglandin D2 Mediated Diseases
10/25/2007US20070249682 Novel CD40:CD154 binding interruptor compounds and use thereof to treat immunological complications
10/25/2007US20070249676 Cyanoguanidine prodrugs
10/25/2007US20070249630 Phenethanolamine derivatives for treatment of respiratory diseases
10/25/2007US20070249618 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression
10/25/2007US20070249617 3-(6-p-Tolyl-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane; treatment of psychotic disorders such as schizophrenia, mania, depression and anxiety; neurodegenerataive disorders such as senile dementia, Alzhelmer's disease and other intellectual impairment disorders
1 ... 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 ... 633